T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.

ABSTRACT:

SUBMITTER: Blixt L 

PROVIDER: S-EPMC8968881 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature